PEGASUS UNVEILS NEW BRAND IDENTITY AS IT CELEBRATES A YEAR AS PART OF ASHFIELD
May 25, 2017 | Ashfield, Pegasus, UDG Healthcare
Pegasus, an Ashfield company, part of UDG Healthcare plc, has unveiled a new brand identity signaling its successful integration with the global business, a year on from acquisition. Conceived by Pegasus’s in-house creative services team, the new look now lives across its internal and external channels.
Managing Director, Simon Hackett comments: “Its strength is in its simplicity, and our compelling mission of ‘inspiring healthy decisions’ remains at its heart. It uses strong graphic devices alongside striking campaign imagery to bring to life our personality and creativity, all backed by the strength and experience of Ashfield.”
The new brand is just one part of the agency’s continuous evolution. Fixed on its course to inspire healthy decisions through creative integrated communications, Pegasus has built a team of 110 people working with a ‘health first, sector second’ approach. The agency’s capability now spans research & insights, strategic planning, media & influencer relations, creative services, digital & social marketing and corporate services. Its swift growth has led to the opening of a new office in Macclesfield to capitalise on talent recruitment and business development opportunities in the North, as well as being able to work more closely with other Ashfield teams.
And Pegasus hasn’t stopped innovating either. Earlier this year, Pegasus launched its bespoke framework for planning in health (CHANGE) which uses behaviour change theory to add greater rigour to its strategic consultancy, and has been developed in collaboration with UCL’s Centre for Behaviour Change. It has also invested in its creative team and last year was shortlisted in the Cannes Lion Health awards. In the last 12 months, Pegasus has received five ‘Consultancy of the Year’ titles across global markets and disciplines.
Hackett explains: “Our brand is clearly a critical part of our business. For me our refreshed identity signifies more than just a strong, new look. It is a symbol of our increased strength and potential in terms of global reach, therapy area experience and service expertise. Being plugged in to the Ashfield network means we’re able to provide end-to-end solutions to health organisations across the world, offer our people greater scope in their roles, and ultimately realise our mission of inspiring healthy decisions amongst more people, in more ways.”
David Moore, Executive Director at Ashfield Healthcare Communications, agrees: “The new identity is sharp, creative and impactful and brings Pegasus firmly into our group, without diluting the unique identity that attracted us to the business in the first place. But for us the brand is just one part of the company’s value. Since we acquired Pegasus, the team has opened new revenue opportunities, developed our strategic communications and behaviour change offer and helped build our patient-centric communications focus. An incredible year and the first of many, I am sure.”
ENDS
For more information about Pegasus, supporting imagery, or to arrange an interview with Simon Hackett, contact Amy Simmons on 01273 712000 / asimmons@thisispegasus.co.uk
NOTES TO EDITORS
About Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching campaigns across industries and channels in a health first, sector second approach. 110 specialists span earned and owned channels, technologies, and audiences ranging from consumers to healthcare professionals. And as part of Ashfield Healthcare Communications, we have a global footprint across 21 countries and every conceivable therapy and service area. Being plugged in to this wider network means we’re able to provide end-to-end solutions to healthcare organisations across the world. In 2016, we were proud to receive five ‘Consultancy of the Year’ titles. For more information, go to www.thisispegasus.co.uk
About Ashfield Healthcare Communications
Ashfield Healthcare Communications, part of UDG Healthcare plc, provides global solutions for clients, adding value through unique insights and tailored, scientifically rigorous, multichannel, healthcare communications offerings. Its mission is to improve lives by helping healthcare professionals and patients get the medicines, knowledge, and support they need. Ashfield Healthcare Communications’ multichannel and specialist agencies include ACUMED, Ashfield Digital & Creative, Ashfield Healthcare Communications K.K., BlueMomentum, CircleScience, Clinical Bridges, CodonMedical, FireKite, Galliard, Gardiner-Caldwell Communications, GeoMed, iMed Comms, Infusion, InterPhase Consult, Nyxeon, Pegasus, Physicians World Europe, QXV Comms, Scientific Connexions, Seren Communications, StemScientific, Watermeadow Medical, and Zoetic Science. For more information, go to www.ashfieldhealthcarecommunications.com
About Ashfield
Ashfield Commercial & Medical Services, part of UDG Healthcare plc, is a global leader in providing outsourced healthcare services to pharmaceutical, device and biotech companies. The company has 6,000 employees, operating in 22 countries and delivering services in over 50 countries across Europe, North America, South America and Asia and works with more than 250 companies, including all the world’s top 25 pharmaceutical companies. Its mission is to partner with its clients, improving lives by helping healthcare professionals and patients get the medicines, knowledge and support they need. Ashfield’s provides contract sales teams, customer service reps, medical science liaison officers, remote detailing, nurse educators, medical information, healthcare communications, market access, market research, training, event management, digital, creative and pharmacovigilance services. For more information, go to www.ashfieldhealthcare.com
This content was provided by Inizio
Company Details
Latest Content from Inizio
Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...
AI in practice: 4 real-world use cases in health and life sciences
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...
How will AI change field training?
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.
MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke
The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...
Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
How DataGateway unified oncology data for real-world insights & market intelligence
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.